Benitec Biopharma Inc (BNTC): Balans kapitallashuviga qarzlar

Benitec (BNTC) kompaniyasining korporativ logotipi

GURU.Markets platformasidagi Benitec Biopharma Inc. (BNTC) bozor dinamikasi R&D ni qo'llab-quvvatlovchi biosimpllarning barqaror ixtisoslashtirilgan transportiga tayanadi va joriy ko'rsatkich 0.00 ni tashkil etadi. Biznesning o'sishi BB-301 dori vositasining muvaffaqiyati va sanoat gigantlarining potentsial qiziqishi bilan harakatlanmoqda. Shu bilan birga, mustahkam patent himoyasi va qat'iy tartibga soluvchi nazorat raqobatchilar uchun kirishning yuqori to'sig'ini yaratadi.

Benitec Biopharma Inc. (BNTC) - Balans qiymatiga qarzlar 04.07.2022dan 28.10.2026gacha

Benitec Biopharma Inc (BNTC) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Benitec Biopharma Inc.|BNTC - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Benitec Corp|BNTC - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Benitec Biopharma|BNTC - Kompaniyaning xususiy kapitali|Bozor qiymatining balans qiymatiga nisbati benitec.com|BNTC - Biznesning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Benitec Biopharma Inc.|BNTC - Uzoq muddatli qarzdorlikning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Benitec|BNTC - Kompaniyaning yig'indi qarzdorligi|Balans kapitallashuviga qarzlar Benitec Corp
Kompaniyaning fundamental tahlili:Benitec Biopharma Inc. - BNTC
Benitec Corp brendining mahsuloti

Ushbu ko'rsatkich umumiy qarzdorlikning kapitalga nisbatini aniqlaydi, bu esa fundamental tahlil davomida moliyaviy leveraj va defolt xavfini baholash imkonini beradi. Umumiy qarzdorlikning kitob kapitalizatsiyasiga nisbatidagi o'zgarishlarni tahlil qilish orqali, investor Benitec Biopharma Inc. (BNTC) o'zining ddRNAi tadqiqotlarini va strategik ittifoqlar orqali bioinzheneriya patentlarini sotib olishni balansni majburiyatlar bilan ortiqcha yuklamagan holda qanchalik agressiv moliyalashtirayotganini tushunishi mumkin.

Benitec Biopharma Inc. raqobatchilari

Balans kapitallashuviga qarzlar TEM (Tempus AI Inc)|Balans kapitallashuviga qarzlar qiagen.com QGEN|IONS - Balans kapitallashuviga qarzlar|RGEN - Qarzning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar RNA|CRSP (CRISPR) - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati GeneDx Holdings Corp. (WGS)|Qarzning balans qiymatiga nisbati ultragenyx.com|BEAM (Beam Therapeutics) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar Sarepta Therapeutics SRPT|Qarzning balans qiymatiga nisbati Twist Bio (TWST)|Qarzning balans kapitaliga nisbati 10x TXG|NTLA (Intellia Therapeutics) - Balans kapitallashuviga qarzlar|STOK - Balans qiymatiga qarzlar|BLFS (BioLife Solutions) - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Wave Life Sciences Ltd|MAZE - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Sionna Corp|Balans kapitallashuviga qarzlar Prime Medicine, Inc. (PRME)|Qarzning balans kapitallashuviga nisbati tayshagtx.com (TSHA)|Balans kapitallashuviga qarzlar QURE|MeiraGTx Holdings - Sof aktivlarga qarzlar|RGNX (Regenxbio) - Qarzning balans kapitallashuviga nisbati|SLDB: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Ocugen, Inc. (OCGN)|pacb.com (PACB) - Qarzlarning balans kapitallashuviga nisbati|DSGN - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Rocket Pharma|Balans kapitallashuviga qarzlar FDMT|Balans kapitallashuviga qarzlar LXEO (lexeotx.com)|Qarzning balans kapitallashuviga nisbati Korro Bio|editasmedicine.com - Qarzning sof aktivlarga nisbati|SLN: Qarzning balans kapitallashuviga nisbati|PRQR - Qarzning balans qiymatiga nisbati|CDXS: Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar Sangamo BioSciences|NAUT - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati metagenomi.co|DTIL (Precision BioSciences, Inc.) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar GBIO (generationbio.com)|BOLD - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Exicure Inc. XCUR|IMNN: Balans kapitallashuviga qarzlar|Phio Pharmaceuticals (PHIO) - Qarzning balans qiymatiga nisbati|mustangbio.com - Qarzning balans qiymatiga nisbati|TransCode Therapeutics, Inc. (RNAZ) - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar Bionano Genomics Inc.|Qarzning balans kapitallashuviga nisbati APDN|Qarzning balans kapitallashuviga nisbati bluebird bio, Inc. BLUE|Qarzning balans qiymatiga nisbati immunoprecise.com IPA|Qarzning balans qiymatiga nisbati Omega Therapeutics, Inc. (OMGA)|Qarzning balans kapitaliga nisbati Singular Genomics Systems, Inc. OMIC|RGLS: Balans kapitallashuviga qarzlar|SYRS - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar Telesis Bio, Inc.|TCON (traconpharma.com) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati Unity Biotechnology, Inc. (UBX)